News & Updates
Filter by Specialty:
CtDNA-guided surveillance catches postoperative CRC recurrences early for curative treatment
For patients who have undergone curative resection for nonmetastatic colorectal cancer (CRC), performing circulating tumour DNA (ctDNA) methylation analysis during surveillance facilitates earlier detection of recurrences suitable for curative therapy, according to interim data from the phase III FIND trial.
CtDNA-guided surveillance catches postoperative CRC recurrences early for curative treatment
2 hours ago
Statin exposure associated with longer OS in apalutamide-treated patients with advanced prostate cancer
A study using individual patient data from the SPARTAN and TITAN randomized clinical trials has found that statin exposure was associated with superior overall survival (OS) among all patients with advanced prostate cancer (PC) who were treated with apalutamide.
Statin exposure associated with longer OS in apalutamide-treated patients with advanced prostate cancer
28 Aug 2025
Dalpiciclib-pyrotinib-endocrine therapy passes trial for breast cancer
Treatment with dalpiciclib combined with pyrotinib and endocrine therapy exhibits antitumour activity with no new safety signals in estrogen receptor (ER)-positive HER2-positive advanced breast cancer, as shown by the results of a phase II trial.
Dalpiciclib-pyrotinib-endocrine therapy passes trial for breast cancer
25 Aug 2025
Lung nodule surveillance programme helps detect early-stage lung cancer
A lung nodule surveillance programme at Queen Mary Hospital (QMH) facilitates diagnosis of early-stage lung cancer. Data from the programme’s first year of implementation showed a higher proportion of early-stage lung cancer diagnoses compared with the Hong Kong Cancer Registry’s (HKCR) annual report.